AstraZeneca PLCAZN:NYQ

1.51 / 2.16 %
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Mar 31 2015 21:06 BST.


On Tuesday, AstraZeneca PLC (AZN:NYQ) closed at 68.43, 10.74% above the 52 week low of 61.80 set on Apr 15, 2014.

52-week range
Apr 15 2014
May 01 2014
Markit short selling activity
Day high69.25
Day low68.24
Previous close69.94
Average volume1.33m
Shares outstanding1.26bn
Free float1.26bn
P/E (TTM)71.68
Market cap88.82bn USD
EPS (TTM)0.9757 USD
Annual div (IAD)2.80 USD
Annual div yield (IAD)4.00%
Div ex-dateFeb 18 2015
Div pay-dateMar 23 2015
Data delayed at least 15 minutes, as of Mar 31 2015 21:06 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AstraZeneca PLC-4.23 %-0.68 %-4.21 %+5.47 %+53.02 %
S&P 500 INDEX-1.13 %-1.74 %+4.85 %+10.44 %+76.83 %
Data delayed at least 15 minutes, as of Mar 31 2015 21:06 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.